IP Library Granted Patent US 11,072,823
Granted Patent B2
US 11,072,823 · App. 16/231,002 · Granted Jul 27, 2021

Compositions including a double stranded nucleic acid molecule and a stem-loop oligonucleotide

Inventors: Vladimir L. Makarov (Ann Arbor, MI); Emmanuel Kamberov (Ann Arbor, MI); Brendan J. Tarrier (Belleville, MI)
Assignee: Takara Bio USA, Inc.
C12Q1/6853C12N15/1068C12P19/34C12Q1/686C12Q1/6855C12Q1/6865
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,072,823
App. No.
16/231,002
Granted
Jul 27, 2021
Kind
B2
Abstract

The present invention concerns preparation of DNA molecules, such as a library, using a stem-loop oligonucleotide. In particular embodiments, the invention employs a single reaction mixture and conditions. In particular, at least part of the inverted palindrome is removed during the preparation of the molecules to facilitate amplification of the molecules. Thus, in specific embodiments, the DNA molecules are suitable for amplification and are not hindered by the presence of the palindrome.

Claims (20)

1. A kit comprising:

a stem-loop oligonucleotide comprising an inverted repeat and a loop, wherein the stem loop oligonucleotide further comprises a 5′ end that lacks a phosphate;

a ligase; and

a polymerase.

2. The kit according to claim 1 , wherein the stem loop oligonucleotide further comprises:

(a) a non-replicable base or sequence; or

(b) at least one deoxy-uridine.

3. The kit according to claim 2 , wherein the stem loop oligonucleotide comprises a non-replicable base or sequence.

4. The kit according to claim 3 , wherein at least part of the non-replicable base or sequence is present in the loop of the oligonucleotide or in a sequence of the stem adjacent to the loop.

5. The kit according to claim 4 , wherein the non-replicable base or sequence comprises an abasic site or sequence, hexaethylene glycol, or a bulky chemical moiety attached to the sugar-phosphate backbone or the base.

6. The kit according to claim 2 , wherein the stem loop oligonucleotide further comprises at least one deoxy-uridine.

7. The kit according to claim 6 , wherein the loop of the stem-loop oligonucleotide comprises at least one deoxy-uridine.

8. The kit according to claim 7 , wherein the kit further comprises deoxy-uridine glycosylase.

9. The kit according to claim 1 , wherein the ligase is a DNA ligase.

10. The kit according to claim 1 , wherein the polymerase is a DNA polymerase.

11. The kit according to claim 1 , wherein the stem-loop oligonucleotide comprises a 5′ OH.

12. The kit according to claim 1 , wherein the kit further comprises an endonuclease.

13. The kit according to claim 1 , wherein the kit further comprises a thermostable polymerase.

14. The kit according to claim 13 , wherein the kit further comprises a universal primer.

15. The kit according to claim 14 , wherein the kit further comprises dNTPs.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2019
From: MAKAROV, VLADIMIR L.; KAMBEROV, EMMANUEL; TARRIER, BRENDAN J.
To: RUBICON GENOMICS, INC.
Reel/Frame 048603/0472 →
MERGER Recorded Mar 14, 2019
From: RUBICON GENOMICS, INC.
To: TAKARA BIO USA, INC.
Reel/Frame 048603/0484 →
Continuity (10)
Continuation 15674468 · Aug 10, 2017
Continuation 15430803 · Feb 13, 2017
Continuation 14250538 · Apr 11, 2014
Continuation 13766607 · Feb 13, 2013
Continuation 13286937 · Nov 1, 2011
Continuation 12892359 · Sep 28, 2010
Continuation 12270850 · Nov 13, 2008
Continuation 11366222 · Mar 2, 2006
Provisional Application 60704932 · Aug 2, 2005
Related Publication 20190119741A1 · Apr 25, 2019